<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38262421</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-3824</ISSN><JournalIssue CitedMedium="Internet"><Volume>236</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Klinische Padiatrie</Title><ISOAbbreviation>Klin Padiatr</ISOAbbreviation></Journal><ArticleTitle>Subjective Smell Disturbances in Children with Sars-Cov-2 or Other Viral Infections do not Correspond with Olfactory Test Results.</ArticleTitle><Pagination><StartPage>129</StartPage><EndPage>138</EndPage><MedlinePgn>129-138</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-2208-6245</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Olfactory dysfunction associated with SARS-CoV-2 infection in children has not been verified by a validated olfactory test. We aimed to determine whether these complaints are objectifiable (test-based hyposmia), how often they occur during acute SARS-CoV-2 infection compared to other upper respiratory tract infections (URTI), as well as in children recovered from COVID-19 compared to children with long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Olfactory testing (U-sniff test; hyposmia&lt;8 points) and survey-based symptom assessments were performed in 434 children (5-17 years; 04/2021-06/2022). 186 symptom-free children served as controls. Of the children with symptoms of acute respiratory tract infection, SARS-CoV-2 PCR test results were positive in 45 and negative in 107 children (URTI group). Additionally, 96 children were recruited at least 4 weeks (17.6&#xb1;15.2 weeks) after COVID-19, of whom 66 had recovered and 30 had developed long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to controls (2.7%), hyposmia frequency was increased in all other groups (11-17%, p&lt;0.05), but no between-group differences were observed. Only 3/41 children with hyposmia reported complaints, whereas 13/16 children with complaints were normosmic, with the largest proportion being in the long-COVID group (23%, p&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Questionnaires are unsuitable for assessing hyposmia frequency in children. Olfactory complaints and hyposmia are not specific for SARS-CoV-2 infection. The number of complaints in the long-COVID group could result from aversive olfactory perception, which is undetectable with the U-sniff test.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grote</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Pneumology and Allergology, University Children's Hospital Regensburg at Campus St. Hedwig, University Regensburg, University Hospital Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerzel</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pneumology and Allergology, University Children's Hospital Regensburg at Campus St. Hedwig, University Regensburg, University Hospital Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukasik</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose and Throat, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallon</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlegtendal</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarzbach</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Ackeren</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose and Throat, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volkenstein</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose and Throat, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinkmann</LastName><ForeName>Folke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ruhr University of Bochum Faculty of Medicine, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatric Pneumology, University Hospital Schleswig Holstein Campus L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Airway Research Center North (ARCN), German Center for Lung Research, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Subjektive Geruchsst&#xf6;rungen bei Kindern mit SARS- CoV- 2 Infektion und anderen Atemwegsinfektionen korrelieren nicht mit Geruchstestergebnissen.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Klin Padiatr</MedlineTA><NlmUniqueID>0326144</NlmUniqueID><ISSNLinking>0300-8630</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText Label="HINTERGRUND" NlmCategory="UNASSIGNED">Geruchsst&#xf6;rungen im Zusammenhang mit einer SARS-CoV-2-Infektion bei Kindern wurden bisher nicht durch einen validierten Geruchstest untersucht. Ziel dieser Studie war es, festzustellen, ob diese Beschwerden objektivierbar sind (testbasierte Hyposmie), ob sie bei einer akuten SARS-CoV-2-Infektion h&#xe4;ufiger auftreten als bei anderen Infektionen der oberen Atemwege (URTI) und ob sich die H&#xe4;ufigkeit bei Kindern, die sich von COVID-19 erholt haben, im Vergleich zu Kindern mit Long-COVID unterscheiden.</AbstractText><AbstractText Label="METHODEN" NlmCategory="METHODS">Geruchstestung (U-Sniff-Test; Hyposmie&lt;8 Punkte) und umfragebasierte Symptomerfassung wurden bei 434 Kindern (5&#x2013;17 Jahre; 04/2021&#x2013;06/2022) durchgef&#xfc;hrt. 186 symptomfreie Kinder dienten als Kontrollen. Von den Kindern mit Symptomen einer akuten Atemwegsinfektion waren die Ergebnisse des SARS-CoV-2 PCR-Tests bei 45 Kindern positiv und bei 107 negativ (URTI-Gruppe). Zus&#xe4;tzlich wurden 96 Kinder mindestens 4 Wochen (17,6&#xb1;15,2 Wochen) nach COVID-19 rekrutiert, von denen 66 genesen waren und 30 Long-COVID entwickelt hatten.</AbstractText><AbstractText Label="ERGEBNISSE" NlmCategory="UNASSIGNED">Im Vergleich zur Kontrollgruppe (2,7%) war die H&#xe4;ufigkeit einer Hyposmie in allen anderen Gruppen erh&#xf6;ht (11&#x2013;17%, p&lt;0,05), aber es wurden keine Unterschiede zwischen den Gruppen festgestellt. Nur 3/41 Kinder mit Hyposmie berichteten &#xfc;ber Beschwerden, w&#xe4;hrend 13/16 Kinder mit Beschwerden normosmisch waren, mit dem gr&#xf6;&#xdf;ten Anteil in der Long-COVID-Gruppe (23%, p&lt;0,05).</AbstractText><AbstractText Label="SCHLUSSFOLGERUNG" NlmCategory="UNASSIGNED">Frageb&#xf6;gen sind f&#xfc;r die Beurteilung der Hyposmieh&#xe4;ufigkeit bei Kindern ungeeignet. Geruchsbeschwerden und Hyposmie sind nicht spezifisch f&#xfc;r eine SARS-CoV-2-Infektion. Die h&#xe4;ufigen Beschwerden in der Long-COVID-Gruppe k&#xf6;nnten auf eine mit dem U-Sniff-Test nicht nachweisbare, aversive Geruchswahrnehmung zur&#xfc;ckzuf&#xfc;hren sein.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>24</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38262421</ArticleId><ArticleId IdType="doi">10.1055/a-2208-6245</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>